IL1B and Alzheimer disease: AD-IMF potentiated hippocampal insulin signaling (pAkt→pGSK-3β) and reduced mRNA expression of TNF-α and IL-1β, inflammatory markers, in the hippocampus but AD-KD rather impaired them.